Hubungan Ansietas dengan Penyakit Parkinson pada Pasien Rawat Jalan

  • Yoga Setia Kurrniawan PPDS DepartemenNeurologi, Fakultas Kedokteran, Universitas Andalas
  • Yuliarni Syafrita Staf Departemen Neurologi, Fakultas Kedokteran, Universitas Andalas
  • Restu Susanti Staf Departemen Neurologi, Fakultas Kedokteran, Universitas Andalas
Keywords: nsietas; hamilton anxiety rating scale; parkinson

Abstract

Ansietas merupakan gejala non-motor terbanyak pada penyakit Parkinson (PD) yang sangat mempengaruhi
kualitas hidup (QoL) pasien meskipun sering kali terabaikan pada praktik klinis. Tujuan penelitian ini adalah
untuk melihat hubungan antara angka kejadian ansietas (menggunakan Hamilton Anxiety Rating Scale (HARS)
dan faktor yang mempengaruhinya. Sampel adalah pasien PD di Poliklinik Neurologi RSUP Dr. M. Djamil Padang
yang sesuai dengan kriteria inklusi dan eksklusi. Analisis univariat dilakukan untuk mengetahui distribusi umum
dan uji bivariat dilakukan untuk menilai faktor yang berhubungan dan korelasinya. Subyek penelitian sebanyak
60 pasien. Sebagian besar subyek adalah laki- laki (55%) dengan rerata usia 59 (58.05 ± 9.7) tahun dan durasi penyakit 6.35 ± 5.29 tahun. Dengan pemeriksaan Hamilton Anxiety Rating Scale (HARS), diperoleh 38.3% penderita Parkinson dengan ansietas. Terdapat perbedaan yang bermakna antara status perkawinan, durasi sakitm dan derajat penyakit dengan kejadian ansietas (p<0.05) pada pasien dengan penyakit Parkinson. Tidak terdapat perbedaan yang bermakna antara usia dan jenis kelamin dengan kejadian ansietas pada pasien dengan penyakit Parkinson. Perlu skrining dan penatalaksanaan yang tepat dalam mengelola ansietas pada pasien dengan penyakit
Parkinson.

References

1. Keener AM, Bordelon YM. Parkinsonism. Seminars in Neurology. 2016 Aug 1;36(4):330–4.
2. Massano J, Bhatia KP. Clinical approach to Parkinson’s disease: Features, diagnosis, and principles
of management. Cold Spring Harbor Perspectives in Medicine [Internet]. 2012 [cited 2021 Feb
13];2(6). Available from: /pmc/articles/PMC3367535/
3. Borgonovo J, Allende-Castro C, Laliena A, Guerrero N, Silva H, Concha ML. Changes in neural
circuitry associated with depression at pre-clinical, pre-motor and early motor phases of
Parkinson’s disease [Internet]. Vol. 35, Parkinsonism and Related Disorders. Elsevier Ltd; 2017
[cited 2021 Feb 13]. p. 17–24. Available from: http://www.prdjournal.com/article/S1353802016304540/fulltext
4. Dissanayaka NNNW, White E, O’Sullivan JD, Marsh R, Pachana NA, Byrne GJ. The clinical
spectrum of anxiety in Parkinson’s disease [Internet]. Vol. 29, Movement Disorders. John Wiley
and Sons Inc.; 2014 [cited 2021 Feb 13]. p. 967–75. Available from:
https://pubmed.ncbi.nlm.nih.gov/25043800/
5. Reynolds GO, Hanna KK, Neargarder S, Cronin-Golomb A. The relation of anxiety and cognition
in Parkinson’s disease. Neuropsychology. 2017 Sep 1;31(6):596–604.
6. Broen MPG, Narayen NE, Kuijf ML, Dissanayaka NNW, Leentjens AFG. Prevalence of anxiety
in Parkinson’s disease: A systematic review and meta-analysis [Internet]. Vol. 31, Movement
Disorders. John Wiley and Sons Inc.; 2016 [cited 2021 Feb 13]. p. 1125–33. Available from:
https://pubmed.ncbi.nlm.nih.gov/27125963/
7. Menon B, Nayar R, Kumar S, Cherkil S, Venkatachalam A, Surendran K, et al. Parkinson’s
Disease, Depression, and Quality-of-Life. Indian Journal of Psychological Medicine [Internet].
2015 Apr 1 [cited 2021 Feb 13];37(2):144–8. Available from: www.ijpm.info
8. Moisan F, Kab S, Mohamed F, Canonico M, Le Guern M, Quintin C, et al. Parkinson disease maleto-female ratios increase with age: French nationwide study and meta-analysis. Journal of
Neurology, Neurosurgery and Psychiatry [Internet]. 2016 Sep 1 [cited 2021 Feb 13];87(9):952–7.
Available from: https://pubmed.ncbi.nlm.nih.gov/26701996/
9. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s disease: A
systematic review and meta-analysis [Internet]. Vol. 29, Movement Disorders. John Wiley and
Sons Inc.; 2014 [cited 2021 Feb 13]. p. 1583–90. Available from:
https://pubmed.ncbi.nlm.nih.gov/24976103/
10. Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease [Internet]. Vol. 124, Journal of
Neural Transmission. Springer-Verlag Wien; 2017 [cited 2021 Feb 13]. p. 901–5. Available from:
https://pubmed.ncbi.nlm.nih.gov/28150045/
11. Pagano G, Ferrara N, Brooks DJ, Pavese N. Age at onset and Parkinson disease phenotype.
Neurology [Internet]. 2016 Apr 12 [cited 2021 Feb 13];86(15):1400–7. Available from:
/pmc/articles/PMC4831034/
12. Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in
Parkinson’s disease [Internet]. Vol. 17, The Lancet Neurology. Lancet Publishing Group; 2018
[cited 2021 Feb 13]. p. 559–68. Available from: https://pubmed.ncbi.nlm.nih.gov/29699914/
13. Khedr EM, Abdelrahman AA, Elserogy Y, Zaki AF, Gamea A. Depression and anxiety among
patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life. Egyptian
Journal of Neurology, Psychiatry and Neurosurgery [Internet]. 2020 Dec 1 [cited 2021 Feb
13];56(1):116. Available from: https://ejnpn.springeropen.com/articles/10.1186/s41983-020-
00253-5
14. Andreadou E, Anagnostouli M, Vasdekis V, Kararizou E, Rentzos M, Kontaxis T, et al. The impact
of comorbidity and other clinical and sociodemographic factors on health-related quality of life in
Greek patients with Parkinson’s disease. Aging and Mental Health. 2011 Sep;15(7):913–21.
15. Hanna KK, Cronin-Golomb A. Impact of anxiety on quality of life in parkinson’s disease.
Parkinson’s Disease [Internet]. 2012 [cited 2021 Feb 13];2012. Available from:
/pmc/articles/PMC3236448/
16. Chuquilín-Arista F, Álvarez-Avellón T, Menéndez-González M. Prevalence of Depression and
Anxiety in Parkinson Disease and Impact on Quality of Life: A Community-Based Study in Spain.
Journal of Geriatric Psychiatry and Neurology [Internet]. 2020 Jul 1 [cited 2021 Feb 13];33(4):207–
13. Available from: https://pubmed.ncbi.nlm.nih.gov/31597514
Published
2022-04-25
Section
Articles